Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies

Journal of Hepatology

Volumn 24, Issue 3, 1996, Pages 308-312

  Calleja, Jose Luis ^a   Albillos, Agustín ^a   Cacho, Guillermo ^a   Iborra, Jerónimo ^a   Abreu, Luis ^a   Escartín, Pedro ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

autoimmunity; corticosteroids; HCV RNA; interferon

Indexed keywords

ALPHA2B INTERFERON; AUTOANTIBODY; ENDOGENOUS COMPOUND; PREDNISONE; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029939341     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80009-2     Document Type: Article

References (27)

1. Durand JM, Lefevre P, Harle JR, Boucrat J, Vitvinsky A, Soubeyrand J. Cutaneous vasculitis and cryoglobulinaemia type 2 associated with hepatitis C infection. Lancet 1991; 337: 499-500.
2. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-5.
3. Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F, Deforges L, Duvoux C, Zafrani ES, Duval J, Dhumeaux D. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19: 841-8.
4. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D. Lymphocytic sialoadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321-3.
5. Johnson RJ, Gretch DR, Yarnabe H, Hart J, Bacchi CE, Hartwell P, Conser WG, Corey L, Wener MH, Alpers CE, Wilson R. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465-70.
6. Martin P, Di Bisceglie AM, Kassianides C, Lisker MM, Hoofnagle JH. Rapidly progressive non A-non B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 1989; 97: 1559-61.
7. Fong TL, Valinluck B, Govindarajan S, Charboeau F, Adkins RH, Redeker AG. Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 1994; 107: 196-9.
8. Alter MJ, Margolis HR, Krawcyzinski K, Judson FM, Mares A, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ. The natural history of community-acquired hepatitis C in United States. N Engl J Med 1992; 327: 1899-905.
9. Ferrari C, Valli A, Gallet L, Penna A, Scacaglia P, Giuberti T, Schianchi C, Missale G, Manin MG, Fiaccadori F. T cell response to structural and non-structural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infection. Hepatology 1994; 19: 286-95.
10. Magrin S, Craxi A, Fabiano C, Simonetti RG, Fiorentino G, Marino L, Diquattro O, Di Marco V, Loicano O, Volpes R, Almasio P, Urdea MS, Neuwald P, Sanchez-Pescador R, Petmer J, Wilber JC, Pagliaro L. Hepatitis C viremia in chronic liver disease: relationship to interferon alpha or corticosteroid treatment. Hepatology 1994; 19: 273-79.
11. Papo T, Marcellin P, Bernuau J, Durand F, Poynard T, Benhamou JP. Autoimmune chronic hepatitis exacerbated by alpha interferon. Ann Intern Med 1992; 116: 51-3.
12. Shindo M, Di Bisceglie AM, Hoofnagle JH. Acute exacerbation of liver disease during interferon alpha therapy for chronic hepatitis C. Gastroenterology 1992; 102: 1406-8.
13. Mayet WJ, Hess G, Geken G, Rossol S, Voth R, Manns M, Meyer zum Büschenfelde KH. Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 1989; 10: 24-8.
14. Lisker-Melman H, Di Bisceglie AM, Usala SJ, Weintranb B, Murray LM, Hoofnagle JH. Development of thyroid disease during therapy of chronic viral hepatitis with alpha-interferon. Gastroenterology 1992; 102: 2155-60.
15. Lenzi M, Ballardini G, Fusconi M, Cassani F, Seilen L, Volta U, Zauli D, Bianchi FB. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990; 335: 258-9.
16. Desmet W, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
17. Cristiano K, Di Bisceglie AM, Hoofnagle JH, Feinstone SM. Hepatitis C viral RNA in serum in patients with chronic non A-non B hepatitis: detection by polymerase chain reaction using multiple primers. Hepatology 1991; 14: 51-5.
18. Muratori L, Lenci L, Cataleta M, Giostra F, Cassani F, Ballardini G, Zauli D, Bianchi F. Interferon therapy in liver-kidney microsomal antibody type 1 positive patients with chronic hepatitis C. J Hepatol 1994; 21: 199-203.
19. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 998-1005.
20. Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, Bridger C, Vergani D, Bianchi FB, Williams R. Antibodies to C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 1991; 338: 277-80.
21. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bonkovsky HL. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21: 613-9.
22. Davis GL, Balart L, Schiff ER, and the Hepatitis Interventional Therapy Group. Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized controlled trial. N Engl J Med 1989; 321: 1501-8.
23. Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Coz YL, Valla D, Borotto E, Yamamoto AM, Huraux JM, Opolon P, Homberg JC. Liver-kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 1992; 16: 630-6.
24. Gerd M, Ritter A, Gerken G, Meyer zum Büschenfelde KH, Decker R, Manns MP. Anti GOR and hepatitis C virus in autoimmune liver diseases. Lancet 1992; 339: 267-9.
25. Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P45011D6, a cytochrome P-450 monooxygenase. J Clin Invest 1991; 88: 1370-8.
26. Yamamoto AM, Cresteil D, Homberg JC, Alvarez F. Characterization of anti-liver kidney microsome antibody from hepatitis C virus-positive and negative sera. Gastroenterology 1993; 104: 1762-7.
27. Ma Y, Peakman M, Lobo-Yeo A, Wen L, Lenzi M, Gaken J, Farzaner F, Mieli-Vergani G, Bianchi FB, Vergani D. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal antibody in autoimmune hepatitis and chronic hepatitis C virus infection. Clin Exp Immunol 1994; 97: 94-9.